SCHEMBL3847285

SCHEMBL3847285

COc1ccc(-c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cc23)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.38
PIK3CA P42336 9/20 0.37
GRM4 Q14833 3/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
MTOR P42345 3/20 0.36
PIK3CD O00329 3/20 0.36
PIK3CB P42338 3/20 0.36
PIK3CG P48736 3/20 0.36
PIK3C3 Q8NEB9 2/20 0.36
PIK3R1 P27986 1/20 0.36
PRKDC P78527 1/20 0.36
PDE4D Q08499 1/20 0.36
RICTOR Q6R327 1/20 0.36
RPTOR Q8N122 1/20 0.36
PIP4K2C Q8TBX8 1/20 0.36
MAPKAP1 Q9BPZ7 1/20 0.36
MLST8 Q9BVC4 1/20 0.36
IRAK3 Q9Y616 1/20 0.36
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845311 0.87 ATM (0.38) PIK3CAGRM4PIK3CDPIK3CBPIK3CG
SCHEMBL3851426 0.86 ATM (0.36) PIK3CAGRM4PIK3CDPIK3CBPIK3CG
SCHEMBL3847626 0.82 CSNK1D (0.39) PIK3CAGRM4CSNK1DCSNK1E
SCHEMBL3852071 0.82 MAPK14 (0.36) PIK3CAGRM4CSNK1DCSNK1E
SCHEMBL3855586 0.79 LMNA (0.39) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL3849386 0.78 MAPK14 (0.37) PIK3CAGRM4CSNK1DCSNK1E
SCHEMBL3847140 0.78 CSNK1D (0.35) PIK3CACSNK1DCSNK1E
SCHEMBL3852041 0.78 TDO2 (0.49) TDO2PIK3CAMTORPIK3CDPIK3CB
SCHEMBL3847727 0.77 PIK3CD (0.41) PIK3CAGRM4CSNK1DCSNK1EMTOR
SCHEMBL3850507 0.77 MAP4K4 (0.37) PIK3CACSNK1DCSNK1EMTORPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed